J.I. Paz-Bouza - Concepedia

Author

J.I. Paz-Bouza

Universidad de Salamanca

Also Known As

J I Paz-Bouza, J Paz-Bouza, J.I. Paz-Bouza, Jose I. Paz‐Bouza, José I. Paz-Bouza, José Paz‐Bouza

Publications

298

Citations

H-Index

Concepts

All Affiliations

Universidad de Salamanca Tulane University

About

J.I. Paz-Bouza is an author at Universidad de Salamanca specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	247
2	Endocrinology	3	3	155
3	Cell Biology	2	2	56
4	Health Sciences	1	1	23
5	Public Health	1	1	76

J.I. Paz-Bouza

Publications

288

Citations

H-Index

Page 1

	Year	Citations
Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats. Andrew V. Schally, J.I. Paz-Bouza, Joseph V. Schlosser, Proceedings of the National Academy of Sciences SpermatogenesisFertilityRadiation EffectRadiation ExposureGynecology	1987	76
Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. J.I. Paz-Bouza, Tommie W. Redding, Andrew V. Schally Proceedings of the National Academy of Sciences XenotransplantationGrowth HormoneElectron MicroscopyPancreatic CancerMedicine	1987	60
DNA Aneuploidy by Flow Cytometry Is an Independent Prognostic Factor in Gastric Cancer Mar Abad, Juana Ciudad, Manuel Rodríguez Rincón, Analytical Cellular Pathology Gastric TumoursTumor BiologyFlow CytometryTumoral PathologyGastrointestinal Oncology	1998	39
Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RH Attila Zalatnai, J.I. Paz-Bouza, Tommie W. Redding, The Prostate	1988	31
Transrectal fine needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies J.I. Paz-Bouza, Alberto Órfão, M. Abad, Pathology - Research and Practice UrologyDna Ploidy StatusMedical ImagingHistopathologyPathology	1994	23
Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model. Andrew V. Schally, Abraham I. Kook, E Monje, Proceedings of the National Academy of Sciences UrologyEndocrine-related CancerMedicineHormone-releasing Hormone AgonistTumor Growth	1986	19
Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings Alfonso Dueñas‐González, M.M. Abad-Hernández, Jesús García-Mata, Cancer Letters Tumor BiologyBreast OncologyMedicineP53 ExpressionPathology	1996	17
Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: A preliminary report Parviz M. Pour, Tommie W. Redding, J.I. Paz-Bouza, Cancer Letters MedicineGynecologyAgonist D-trp-6-lh-rhMonthly InjectionCancer Treatment	1988	13
Endoglin as a marker in cervical paragangliomas Nélida Eleno, Annette Düwel, Ángel Nogales Muñoz, Head & Neck	2009	10

Page 1